7 Low-Cost Call Options With High-Profit Potential

7 Low-Cost Call Options With High-Profit Potential

Explore stocks on Coinbase

Buying call options is a lot like (American) football. Sometimes, you run the ball up the middle. And sometimes, you do a misdirection and run a bootleg.

At their core, call options represent a mixture of speculation on time value and intrinsic value. Knowing which one to deploy depends on myriad factors, including confidence in analysts’ price targets and the math that the particular derivatives market is giving you. Frankly, some markets will be more robust than others, thus necessitating a shift in strategy.

For this article, we’re going to assume that you already did your due diligence and are interested in the companies listed below. Here, the focus will be on finding not the cheapest option outright but the lowest-cost ideas that should net you a profit based on Wall Street’s guidance.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Without further delay, let’s dive into compelling call options.

CoreCivic (CXW)

A close-up shot of a long, empty prison hallway.
A close-up shot of a long, empty prison hallway.

Source: rawf8/Shutterstock

For those interested in private prison CoreCivic (NYSE:CXW), investors may want to consider the CXW Dec 20 ’24 15.00 Call. Among all the ideas that pinged in CXW’s unusual options screener, the $15 call – which expires on Dec. 20 – is arguably the most viable.

That’s because analysts rate shares a unanimous strong buy with a $17.33 average price target. Around December, it’s quite possible that CXW will trade for around $16.88. If it turns out that the security reaches this price earlier than December, we should be golden. With a Friday closing price of $2.28 and only a bid-ask spread of 9.09% (as represented by the midpoint price), the contract could carry a high premium.

Further, political forces could also favor CoreCivic, especially if the polls suggest that former President Donald Trump is winning voters with his law-and-order message. Thus, a combination of outside fundamentals and an intriguing price point makes this one of the call options to consider.

Fusion Pharmaceuticals (FUSN)

medicine research, pharmaceutical background, LJPC stock
medicine research, pharmaceutical background, LJPC stock

Source: Sisacorn / Shutterstock.com

As one of the lesser-known entities, Fusion Pharmaceuticals (NASDAQ:FUSN) doesn’t exactly have the most robust derivatives market. However, it happens to be one of the more popular entities, with FUSN gaining almost 47% on a year-to-date basis. If betting on shares in the open market seems risky, then call options may be the way to go.

In my opinion, the FUSN May 17 ’24 7.50 Call makes the most sense. Sure, at first glance, the option might seem expensive. On Friday, the contract closed at $5.20. Multiply this figure by 100 shares and you get the total premium, $520. Further, if you exercise the contract – that is by 100 shares at $7.50 – the total cost of the option comes out to $1,270.